Trials / Recruiting
RecruitingNCT06439355
Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of the PI-PEG study is to explore the taste functions of the following 3 groups of participants: * healthy volunteers * patients with early Parkinson's disease * patients with incipient Lewy body disease. To this end, the results obtained from taste evoked potentials in each of the 3 groups of participants will be compared with each other and with different nutritional, motor and cognitive data. This study could reveal a difference in cortical processing of gustatory sensory information between patients who have had idiopathic Parkinson's disease progressing for 3 years or less, and patients who have had Lewy body disease progressing for 3 years or less. Indeed, a modification of taste evoked potentials (in terms of latencies) proportional to the degree of cerebral degeneration could be observed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fasting blood test | metabolic assays determination of food intake hormones oxidative stress and neurodegeneration marker assays |
| OTHER | Subject interview | socio-demographic data, medical and family history, treatment taken |
| OTHER | Motor assessment | MDS-UPDRS scale PART III |
| OTHER | Neurocognitive assessment | MoCA and MMSE scales |
| OTHER | Nutritional assessment | anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skin fold, brachial circumference), bioelectrical impedancemetry (fat mass, lean mass, water mass and bone mass) |
| OTHER | Taste tests | Recording of PEGs in response to a sucrose solution and a free fatty acid solution (prepared beforehand) |
Timeline
- Start date
- 2024-05-27
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2024-06-03
- Last updated
- 2024-06-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06439355. Inclusion in this directory is not an endorsement.